ATE130312T1 - Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen. - Google Patents

Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.

Info

Publication number
ATE130312T1
ATE130312T1 AT89111468T AT89111468T ATE130312T1 AT E130312 T1 ATE130312 T1 AT E130312T1 AT 89111468 T AT89111468 T AT 89111468T AT 89111468 T AT89111468 T AT 89111468T AT E130312 T1 ATE130312 T1 AT E130312T1
Authority
AT
Austria
Prior art keywords
polypeptide
cell adhesive
main repeating
repeating cell
adhesive sequences
Prior art date
Application number
AT89111468T
Other languages
English (en)
Inventor
Ikuo Saiki
Norio Nishi
Ichiro Azuma
Seiichi Tokura
Original Assignee
Ichiro Azuma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichiro Azuma filed Critical Ichiro Azuma
Application granted granted Critical
Publication of ATE130312T1 publication Critical patent/ATE130312T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AT89111468T 1988-06-24 1989-06-23 Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen. ATE130312T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63156133A JP2625156B2 (ja) 1988-06-24 1988-06-24 細胞接着活性コア配列の繰り返し構造からなるポリペプチド

Publications (1)

Publication Number Publication Date
ATE130312T1 true ATE130312T1 (de) 1995-12-15

Family

ID=15621045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89111468T ATE130312T1 (de) 1988-06-24 1989-06-23 Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.

Country Status (7)

Country Link
US (1) US5183804A (de)
EP (1) EP0347931B1 (de)
JP (1) JP2625156B2 (de)
AT (1) ATE130312T1 (de)
DE (1) DE68924804T2 (de)
ES (1) ES2081817T3 (de)
GR (1) GR3018096T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395609A (en) * 1989-06-19 1995-03-07 Antisoma Limited Synthetic peptides for use in tumor detection
GB8914020D0 (en) * 1989-06-19 1989-08-09 Antisoma Ltd Synthetic peptides for use in thrombus detection
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
EP0513388A4 (en) * 1990-11-30 1993-06-30 Asahi Glass Company Ltd. Peptide with activity of inhibiting cancer cell infiltration, composite thereof, and cancer metastasis inhibitor
JP2745351B2 (ja) * 1991-02-14 1998-04-28 富士写真フイルム株式会社 ペプチド誘導体及びその用途
EP0567886A3 (de) * 1992-04-21 1994-11-02 Kurashiki Boseki Kk Beschichtungszusammensetzung zur Züchtung von haftenden Tierzellen und Verfahren zur Züchtung der Zellen in serumfreien Verhältnissen.
AU7128494A (en) * 1993-07-09 1995-02-06 Celltech Limited Gelatinase antagonists used for treating cancer
DE19529909C2 (de) * 1995-08-15 1998-04-09 Fresenius Ag Wässrige Spüllösung
EP0793965A3 (de) * 1996-02-29 1999-02-24 Tano, Yasuo Prophylaktische/therapeutische Zusammensetzung für Nachstar
JP2000082661A (ja) 1998-07-02 2000-03-21 Toshiba Corp 加熱装置,加熱装置の評価法及びパタ―ン形成方法
US7060467B2 (en) 2000-03-13 2006-06-13 Monsanto Technology Llc Recombinant proteins containing repeating units
WO2002036073A2 (en) * 2000-11-02 2002-05-10 Smithkline Beecham Corporation Receptor antagonist-lipid conjugates and delivery vehicles containing same
KR100885071B1 (ko) * 2002-05-14 2009-02-25 재단법인서울대학교산학협력재단 세포에 부착하는 올리고펩타이드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988621A (en) * 1985-05-24 1991-01-29 La Jolla Cancer Research Foundation Peptides in cell detachment and aggregation
IL85372A (en) * 1987-02-12 1992-12-01 Us Health Penta to nona-peptides with laminin - like activity having an amino acid sequence and anti- metastatic compositions containing them
IT1222437B (it) * 1987-08-04 1990-09-05 Ellem Ind Farmaceutica Tripeptidi utili come immunostimolanti e nella prevenzione delle metastasi e relativo procedimento di preparazione

Also Published As

Publication number Publication date
DE68924804T2 (de) 1996-05-15
EP0347931A3 (de) 1991-08-07
DE68924804D1 (de) 1995-12-21
EP0347931B1 (de) 1995-11-15
GR3018096T3 (en) 1996-02-29
JP2625156B2 (ja) 1997-07-02
US5183804A (en) 1993-02-02
EP0347931A2 (de) 1989-12-27
JPH02174798A (ja) 1990-07-06
ES2081817T3 (es) 1996-03-16

Similar Documents

Publication Publication Date Title
ATE130312T1 (de) Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.
HUT52527A (en) Process for producing bradiquinine-antagonistic peptides and pharmaceutical compositions containing them as active components
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
ATE399177T1 (de) Derivate therapeutischer peptide
DK0397420T3 (da) Enzymatisk fjernelse af en aminoterminal proteinsekvens
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
ATE256182T1 (de) Neuartiges p- selectin ligandenprotein
FI102759B1 (fi) Menetelmä terapeuttisesti aktiivisten nona- ja dekapeptidien valmistamiseksi
FI892185A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidiyhdisteiden valmistamiseksi
AU1634388A (en) Cyclic anticoagulant peptides
AU1634288A (en) Cyclic anticoagulant peptides
ATE90359T1 (de) Peptide.
ES8707548A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos
DE68908958D1 (de) Peptide.
EP0459624A3 (en) Galactosamine-substituted poly-omega-substituted-l-glutamic and/or-aspartic acid
ATE99322T1 (de) Loesungssynthese eines oktapeptids.
ATE46347T1 (de) Immunostimulierende peptide.
ATE102997T1 (de) Thymosin und tnf-kodierende dna.
DE3867039D1 (de) Vincristin enthaltendes produkt.
DE3855751D1 (en) Hypoglycemische peptide
SE8700761L (sv) Tillempningar av en polypeptid
DE3886655D1 (de) Verfahren zur Herstellung eines Oktapeptids.
RU94019940A (ru) Пептиды, способ их получения, фармацевтическая композиция на их основе и способ лечения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee